Literature DB >> 10688142

Molecular determinants of drug resistance in tuberculosis.

P F Riska1, W R Jacobs, D Alland.   

Abstract

Rapid detection of drug-resistant tuberculosis (TB) has become increasingly important in the era of pandemic human immunodeficiency virus infection and antibiotic resistance. The identification of the molecular correlates of antibiotic resistance in Mycobacterium tuberculosis have engendered the development of DNA-based assays for the identification of drug-resistant TB. This review summarizes the recent discoveries concerning resistance to isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin, amikacin, kanamycin and the quinolones.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10688142

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


  36 in total

1.  Molecular detection of fluoroquinolone-resistance in multi-drug resistant tuberculosis in Cambodia suggests low association with XDR phenotypes.

Authors:  Corinne Surcouf; Seiha Heng; Catherine Pierre-Audigier; Véronique Cadet-Daniel; Amine Namouchi; Alan Murray; Brigitte Gicquel; Bertrand Guillard
Journal:  BMC Infect Dis       Date:  2011-09-28       Impact factor: 3.090

2.  Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes.

Authors:  Hassan Safi; Subramanya Lingaraju; Anita Amin; Soyeon Kim; Marcus Jones; Michael Holmes; Michael McNeil; Scott N Peterson; Delphi Chatterjee; Robert Fleischmann; David Alland
Journal:  Nat Genet       Date:  2013-09-01       Impact factor: 38.330

3.  Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay.

Authors:  Mandira Varma-Basil; Hiyam El-Hajj; Roberto Colangeli; Manzour Hernando Hazbón; Sujeet Kumar; Mridula Bose; Miriam Bobadilla-del-Valle; Lourdes García García; Araceli Hernández; Fred Russell Kramer; Jose Sifuentes Osornio; Alfredo Ponce-de-León; David Alland
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Rapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature coding.

Authors:  Soumitesh Chakravorty; Harsheel Kothari; Bola Aladegbami; Eun Jin Cho; Jong Seok Lee; Sandy S Roh; Hyunchul Kim; Hyungkyung Kwak; Eun Gae Lee; Soo Hee Hwang; Padmapriya P Banada; Hassan Safi; Laura E Via; Sang-Nae Cho; Clifton E Barry; David Alland
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

5.  Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism.

Authors:  Fernanda S Spies; Pedro E Almeida da Silva; Marta O Ribeiro; Maria Lucia Rossetti; Arnaldo Zaha
Journal:  Antimicrob Agents Chemother       Date:  2008-06-09       Impact factor: 5.191

6.  Geographical differences associated with single-nucleotide polymorphisms (SNPs) in nine gene targets among resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  Matt Hoshide; Lishi Qian; Camilla Rodrigues; Rob Warren; Tommie Victor; Henry B Evasco; Thelma Tupasi; Valeriu Crudu; James T Douglas
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

7.  Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.

Authors:  Timothy C Rodwell; Faramarz Valafar; James Douglas; Lishi Qian; Richard S Garfein; Ashu Chawla; Jessica Torres; Victoria Zadorozhny; Min Soo Kim; Matt Hoshide; Donald Catanzaro; Lynn Jackson; Grace Lin; Edward Desmond; Camilla Rodrigues; Kathy Eisenach; Thomas C Victor; Nazir Ismail; Valeru Crudu; Maria Tarcela Gler; Antonino Catanzaro
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

8.  Use of DNA extracts from Ziehl-Neelsen-stained slides for molecular detection of rifampin resistance and spoligotyping of Mycobacterium tuberculosis.

Authors:  A G M Van Der Zanden; E M Te Koppele-Vije; N Vijaya Bhanu; D Van Soolingen; L M Schouls
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

9.  Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Pontus Jureen; Klavdia Levina; Solomon Ghebremichael; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

10.  Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance.

Authors:  Indra L Bergval; Anja R J Schuitema; Paul R Klatser; Richard M Anthony
Journal:  J Antimicrob Chemother       Date:  2009-07-04       Impact factor: 5.790
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.